- NAD+ advertised rate
- $120/month
- Minimum purchase
- 2.5 months
- Minimum checkout price
- $299 total for the listed 2.5-month offer
- Access
- Online intake and provider review
- Laboratory statement
- Catalog FAQ says peptide therapy does not require blood work
Start with the minimum commitment
TRT Nation lists NAD+ at a rounded $120 monthly equivalent with a 2.5-month minimum purchase. Its checkout page supplies the more useful purchase figure: $299 total. The checkout also identifies a 1,000 mg vial, syringes, shipping and unlimited consultations in the offer. Use that stated total rather than multiplying the rounded monthly headline to produce a slightly different amount. State eligibility and clinician approval still apply.
A reader should ask whether the same terms apply to the selected prescription and whether subsequent orders repeat the minimum period. The answer determines both cash needed at enrollment and flexibility later.
The catalog mixes different compounds
NAD+ appears alongside glutathione and sermorelin in TRT Nation's anti-aging catalog. This is a merchandising category, not evidence that all three are peptides or that they have interchangeable functions. NAD+ is a coenzyme. Questions about a growth-hormone-related prescription should not be imported into its review merely because the products share a page.
The brand describes an online intake and a provider assessment. Broad eligibility language on a marketing page does not tell an individual whether an NAD+ prescription is appropriate, particularly when the reason for seeking treatment is an unexplained symptom.
Laboratory costs need a specific answer
The catalog FAQ states that peptide therapy does not require blood work. Readers interested in NAD+ should still ask the clinician what evaluation is appropriate for their own health history and symptoms. A generic category answer does not establish that laboratory work will never be relevant, nor does it verify the price of a test if one is recommended.
For budgeting, record only the tests that are actually required or agreed upon for the proposed plan. Keep optional wellness panels outside the medication subtotal so their cost and purpose remain visible.
The details that make a quote comparable
The checkout identifies a 1,000 mg vial and included syringes, but a complete prescription specification still needs concentration, liquid volume and pharmacy identity. A 2.5-month commercial purchase period does not establish the usable period of an opened container. Ask how the pharmacy's labeled dates and handling instructions align with the proposed supply, and clarify whether fulfillment changes for the individual prescription.
Also establish the refill contact, processing deadline and terms for an order that has already been sent to the pharmacy. If treatment changes during the minimum period, knowing those rules in advance is more valuable than an assumption that unused stock has refundable value.
Where the offer fits
TRT Nation is worth examining for patients comparing a published multi-month commitment with recurring monthly subscriptions. The visible minimum makes it possible to ask a concrete cash-flow question, although the final order details still need confirmation. A reader prioritizing a very small initial payment may evaluate that commitment differently from someone already discussing a longer plan with a clinician.
We do not turn the catalog's energy and cognitive benefit claims into a forecast. Compare care access, pharmacy information and actual commitments, then discuss expected benefits and uncertainties with the treating professional. The cheapest displayed monthly equivalent is not automatically the most suitable or economical choice for a particular patient.
Useful distinctions
- Checkout publishes the $299 minimum purchase total
- Vial amount, supplies, delivery and consultations are identified
- Online care process is described
Limitations to weigh
- At least 2.5 months must be accounted for
- Full NAD+ product specification is not established by the price tile
- Catalog blood-work statement is not individualized clinical advice
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.